Diabetes-related stigma among individuals with type 1 diabetes in Jazan, Saudi Arabia: sociodemographic and clinical correlates - Takeaways - MDSpire

Diabetes-related stigma among individuals with type 1 diabetes in Jazan, Saudi Arabia: sociodemographic and clinical correlates

  • By

  • Husameldin Elsawi Khalafalla

  • Osama Albasheer

  • Fatima A. Elfaki

  • Abdulrahman Hummadi

  • Yahia Solan

  • Rania Hassan

  • Norah Rajeh

  • Taif Solan

  • Huda Mohamed Haroun Adam

  • Stef PJ Kremers

  • June 8, 2026

  • 0 min

Share

  • 1

    Diabetes-related stigma negatively impacts self-management and psychological well-being among individuals with Type 1 diabetes in Jazan, Saudi Arabia.

  • 2

    A study of 299 adults revealed problematic stigma across various domains, particularly in being Treated Differently and overall stigma.

  • 3

    Higher stigma levels were linked to more recent diagnoses, poorer glycemic control, and increased episodes of hypoglycemia and hyperglycemia.

  • 4

    Stigma was more prevalent among females, urban residents, unemployed individuals, and those with lower income or education.

  • 5

    Clinical factors significantly improved the explained variance of stigma, highlighting the need for context-specific research in the region.

Original Source(s)

Diabetes-related stigma among individuals with type 1 diabetes in Jazan, Saudi Arabia: sociodemographic and clinical correlates

  • by Husameldin Elsawi Khalafalla, Osama Albasheer, Fatima A. Elfaki, Abdulrahman Hummadi, Yahia Solan, Rania Hassan, Norah Rajeh, Taif Solan, Huda Mohamed Haroun Adam, Stef PJ Kremers

  • June 8, 2026

Related Content

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

Predictive Models Utilizing Machine Learning for Visual Impairment in Chinese Adults Aged 45 and Older with Cardiovascular Metabolic Conditions: Insights from a Population-Based Analysis Using CHARLS